$0.44
3.35% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
CA45257F2008
Symbol
IPA
Sector
Industry

ImmunoPrecise Antibodies Ltd Target price 2024 - Analyst rating & recommendation

ImmunoPrecise Antibodies Ltd Classifications & Recommendation:

Buy
100%

ImmunoPrecise Antibodies Ltd Price Target

Target Price $6.00
Price $0.44
Potential
Number of Estimates 2
2 Analysts have issued a price target ImmunoPrecise Antibodies Ltd 2025 . The average ImmunoPrecise Antibodies Ltd target price is $6.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 2 Analysts recommend ImmunoPrecise Antibodies Ltd to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ImmunoPrecise Antibodies Ltd stock has an average upside potential 2025 of . Most analysts recommend the ImmunoPrecise Antibodies Ltd stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Apr '24 2025
Estimates
Revenue Million $ 18.16 18.64
16.86% 2.65%

2 Analysts have issued a sales forecast ImmunoPrecise Antibodies Ltd 2025 . The average ImmunoPrecise Antibodies Ltd sales estimate is

$18.6m
Unlock
. This is
5.14% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$19.6m 10.59%
Unlock
, the lowest is
$17.7m 0.32%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $18.2m 16.86%
2025
$18.6m 2.65%
Unlock
2026
$25.3m 35.72%
Unlock
2027
$30.6m 21.10%
Unlock
2028
$36.9m 20.61%
Unlock
2029
$44.6m 20.72%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Apr '24 2025
Estimates
EV/Sales 1.07

Based on analysts' sales estimates for 2025, the ImmunoPrecise Antibodies Ltd stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.12 56.25%
2025
1.07 4.68%
Unlock
2026
0.79 26.32%
Unlock
2027
0.65 17.42%
Unlock
2028
0.54 17.09%
Unlock
2029
0.45 17.17%
Unlock

P/S ratio

Current 0.62 74.07%
2025
0.59 4.88%
Unlock
2026
0.44 26.31%
Unlock
2027
0.36 17.42%
Unlock
2028
0.30 17.09%
Unlock
2029
0.25 17.17%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today